Clade Therapeutics, Inc. — Form D
Clade Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-12. The offering totals $87.1M, of which $45.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-11-12
- Form: D
- Accession: 0001893119-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $87.1M
- Amount sold: $45.9M
- Remaining: $41.2M
- Investors: 31
- Date of first sale: 2021-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-420908
Issuer
- Name: Clade Therapeutics, Inc.
- CIK: 0001893119
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1 KENDALL SQUARE, SUITE B200, CAMBRIDGE, MA, 02139
- Phone: 415-886-7710
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Chad A Cowan | Director | Cambridge, MA |
| Chad A Cowan | Executive Officer | Cambridge, MA |
| Martin A Murphy | Director | Cambridge, MA |
| Daniel A Vasella | Director | Cambridge, MA |
| Jim A Glasheen | Director | Cambridge, MA |
| Jim A Glasheen | Executive Officer | Cambridge, MA |
| Neil A White | Director | Cambridge, MA |
| Leandro A Vetcher | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More